We are already making good progress on our journey – we are on track with integration, although there is a lot still to do. We are embedding our strategic resource allocation choices and rolling out changes to our commercial and innovation operating models, while building a culture to accelerate our performance. There is no change to our announced intention to separate around three years from close of the Consumer Healthcare joint venture, which would be around mid-2022.